Vascepa Logo

Amarin Corporation plc. is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA® (icosapent ethyl), is available by prescription in certain countries, including in the United States. For more information about Amarin, visit www.amarincorp.com. For more information about VASCEPA, visit www.vascepahcp.com.

Vascepa
Icosapent ethyl (IPE) recognized worldwide as an important CV treatment option

Icosapent ethyl (IPE) recognized worldwide as an important CV treatment option

Learn More
Learn more about VASCEPA®: FDA - approved expanded indication

Learn more about VASCEPA®: FDA - approved expanded indication

Learn More
VASCEPA® (icosapent ethyl): There is no substitute

VASCEPA® (icosapent ethyl): There is no substitute

Learn More

Participate in the Passport to Prizes

for your chance to win an iPad, Airpods, or an Apple Watch!